DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Baird Maintains Neutral on HealthEquity, Lowers Price Target to $47

Baird analyst Mark Marcon maintains HealthEquity (NASDAQ:HQY) with a Neutral and lowers the price target from $74 to $47.

Benzinga · 03/17/2020 13:56

Baird analyst Mark Marcon maintains HealthEquity (NASDAQ:HQY) with a Neutral and lowers the price target from $74 to $47.